Home › Research › Prevention and risk
Epidemiology of stroke in Europe and trends for the 21st century
Béjot Y, Bailly H, Durier J, Giroud M.. Presse medicale (Paris, France : 1983), 2016-11-02
Topic: Risk, prevention and care in population studies
Plain-language summary
Despite major improvements in primary prevention and acute treatment over the last decades, stroke is still a devastating disease. At the beginning of the 21st century, the age-standardized incidence of stroke in Europe ranged from 95 to 290/100,000 per year, with one-month case-fatality rates ranging from 13 to 35%. Approximately 1.1 million inhabitants of Europe suffered a stroke each year, and ischemic stroke accounted for approximately 80% of cases. Although global stroke incidence is declining, rates observed in young adults are on the rise, thus suggesting a need for strategies to improve prevention. In addition, because of the ageing population, the absolute number of stroke is expected to dramatically increase in coming years: by 2025, 1.5 million European people will suffer a stroke each year. Beyond vital prognosis, stroke patients are also at increased risk of poor outcome within the first year of the event including re-hospitalisation (33%), recurrent event (7 to 13%), dementia (7 to 23%) mild cognitive disorder (35 to 47%), depression (30 to 50%), and fatigue (35% to 92%), all of them contributing to affect health related quality of life. Given these observations, an urgent development of acute care provision, as well as resources for post-stroke therapeutic strategies, is needed.
What this study adds
Evidence grade: Low
This review reports that within the first year after a stroke, 7% to 23% of patients develop dementia and 35% to 47% develop mild cognitive disorder. It notes that stroke incidence in young adults is rising and that the absolute number of strokes is expected to increase with the ageing population, highlighting stroke prevention and post-stroke care as important.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Béjot, Y., Bailly, H., Durier, J., & Giroud, M. (2016). Epidemiology of stroke in Europe and trends for the 21st century. Presse medicale (Paris, France : 1983). https://doi.org/10.1016/j.lpm.2016.10.003
Vancouver
Béjot Y, Bailly H, Durier J, Giroud M. Epidemiology of stroke in Europe and trends for the 21st century. Presse medicale (Paris, France : 1983). 2016. doi:10.1016/j.lpm.2016.10.003. PMID: 27816343.
BibTeX
@article{bejot2016-27816343,
author = {Béjot, Y. and Bailly, H. and Durier, J. and Giroud, M.},
title = {{Epidemiology of stroke in Europe and trends for the 21st century}},
journal = {Presse medicale (Paris, France : 1983)},
year = {2016},
doi = {10.1016/j.lpm.2016.10.003},
pmid = {27816343},
url = {https://doi.org/10.1016/j.lpm.2016.10.003}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Beyond vital prognosis, stroke patients are also at increased risk of poor outcome within the first year of the event including re-hospitalisation (33%), recurrent event (7 to 13%), dementia (7 to 23%) mild cognitive disorder (35 to 47%), depression (30 to 50%), and fatigue (35% to 92%), all of them contributing to affect health related quality of life.
Why it matters
This review reports that within the first year after a stroke, 7% to 23% of patients develop dementia and 35% to 47% develop mild cognitive disorder. It notes that stroke incidence in young adults is rising and that the absolute number of strokes is expected to increase with the ageing population, highlighting stroke prevention and post-stroke care as important.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Evidence strengthLow
How this study scored 43/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Presse medicale (Paris, France : 1983)) |
| Journal's citation record | 0 / 4 | La Presse Médicale: journal h-index 66 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2016 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 510 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 42.5 citations a year over 12 year(s) since 2016 |
| Impact for its field and year | 5 / 6 | Cited 23.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 3 / 4 | Cited 112 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Maurice Giroud: h-index 71 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Université de Bourgogne: institution h-index 441 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 27816343) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 43 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Prevention and risk from nearby years
Also in Prevention and risk
269 studies in the library are filed under Prevention and risk with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Prevention and risk hub.